The Board of Directors of Ambea AB (publ) ("Ambea") announces that the share repurchase program announced on 29 June 2026 has now been completed.
The objective of the share repurchase program was to enable the shares to be used for capital structure purposes or acquisitions, primarily to ensure that Ambea holds sufficient own shares (together with new shares that may be issued) to be used as consideration in the recommended public offer to the shareholders of Humana AB ("Humana"), which was announced on 29 June 2026 (the "Offer").
Through the completed repurchases, Ambea has now acquired the number of own shares that the company intended to acquire under the share repurchase program.
The share repurchase program was carried out pursuant to the authorisation granted by the Annual General Meeting 2026 and in accordance with Nasdaq Stockholm's Rulebook for Issuers.
Further information regarding the Offer to the shareholders of Humana is available at www.care-for-tomorrow.com/en.
The total number of shares in Ambea amounts to 80,384,424. At the time of this press release, Ambea holds 5,560,658 own shares.
The information was submitted for publication, through the agency of the contact person below, on September 8, 2026, at 10:30 CEST.
Administrative questions
For administrative questions regarding the Offer, please contact your bank or nominee where your shares are registered.
Questions regarding the repurchase program
Benno Eliasson, CFO
E-mail: ir@ambea.se